PI3K Signaling Pathway Analysis 2018: Globally, 1,984 Products that Target Components of the PI3K Signaling Network have Gained Market Approval to Date - ResearchAndMarkets.com

January 22, 2019

DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets” report has been added to ResearchAndMarkets.com’s offering.

PI3K Signaling Pathway Analysis provides a comprehensive assessment of the marketed and pipeline products acting on various components of the phosphoinositide 3-kinase (PI3K) signaling network. The report discusses the significance of the PI3K pathway, including its role in disease, and provides a comprehensive overview of the PI3K marketed and pipeline landscapes.

The report provides a breakdown of the following key signaling pathways within the PI3K network in terms of marketed and pipeline activity: PI3K/AKT/mTOR pathway, Ras/Raf/MEK/ERK pathway, cell survival pathways downstream of AKT, cell-cycle progression pathways downstream of AKT, metabolism pathways downstream of AKT and kinases downstream of phosphoinositide-dependent kinase-1 (PDK1).

An analysis of the marketed and pipeline activity across various nodes (defined as groups of molecules which have the same role in response to a stimulus) within each of these pathways is provided. An examination of the marketed and pipeline products acting on each of these pathways in terms of molecule type and therapy area, and, in the case of pipeline products, novelty and stage of development, provides further granularity.

Additionally, detailed product profiles of key marketed products are provided, which incorporate clinical and commercial perspectives and include historical and forecast annual sales revenues. The report concludes with a discussion of promising late-stage pipeline products.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Marketed Products Landscape

4 Pipeline Products Landscape

5 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/g8z3pj/pi3k_signaling?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005400/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Production and Quality Management



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/22/2019 04:40 AM/DISC: 01/22/2019 04:40 AM


Update hourly